Folger Nolan Fleming Douglas Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
5,097
-27
-0.5% -$1.77K 0.03% 152
2026
Q1
$365K Buy
+5,124
New +$404K 0.03% 140
2024
Q4
Sell
-2,354
Closed -$221K 165
2024
Q3
$221K Buy
+2,354
New +$198K 0.02% 162
2024
Q2
Sell
-2,827
Closed -$257K 164
2024
Q1
$257K Buy
2,827
+4
+0.1% +$333 0.03% 149
2023
Q4
$218K Sell
2,823
-130
-4% -$9.1K 0.02% 160
2023
Q3
$201K Sell
2,953
-451
-13% -$32.8K 0.02% 160
2023
Q2
$277K Sell
3,404
-505
-13% -$40.3K 0.03% 142
2023
Q1
$321K Buy
+3,909
New +$279K 0.04% 129

Other funds holding GEHC

Folger Nolan Fleming Douglas Capital Management's GEHC Position: Q2 2026 in Review

Folger Nolan Fleming Douglas Capital Management reduced its GE HealthCare (GEHC) stake by 0.53% in Q2 2026, selling an estimated $1.77K and leaving 5,097 shares worth $326K. The position accounts for 0.03% of the portfolio, ranked #152.

Folger Nolan Fleming Douglas Capital Management first reported a position in GEHC in Q1 2023 and has held it in 8 quarters since. The position peaked at $365K in Q1 2026. 502 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Folger Nolan Fleming Douglas Capital Management held 5,097 shares of GE HealthCare worth $326K as of Q2 2026.
  • Folger Nolan Fleming Douglas Capital Management sold 27 GE HealthCare shares in Q2 2026, an estimated $1.77K.
  • GE HealthCare made up 0.03% of Folger Nolan Fleming Douglas Capital Management's portfolio in Q2 2026, its #152 holding.
  • Folger Nolan Fleming Douglas Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 8 quarters since.
  • Folger Nolan Fleming Douglas Capital Management's GE HealthCare position peaked at $365K in Q1 2026.
  • 502 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Folger Nolan Fleming Douglas Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.